Maternal Antiretroviral Therapy Is Associated with Lower Risk of Diarrhea in Early Childhood

J Pediatr. 2016 Aug:175:54-60. doi: 10.1016/j.jpeds.2016.04.088. Epub 2016 May 28.

Abstract

Objectives: To identify risk factors, including maternal antiretroviral therapy (ART), for diarrhea in Tanzanian children exposed to HIV during the first 2 years of life.

Study design: Using generalized estimating equations, we analyzed data from a cohort of 2387 Tanzanian children exposed to HIV from age 6 weeks to 2 years, as well as data from their mothers, to determine risk factors for diarrhea in children. Mothers recorded diarrhea in a diary and reported results at visits scheduled every four weeks.

Results: Body mass index was ≥18.5 in 95.6% of mothers. World Health Organization HIV stage was 1/2 for 1255 (87.8%) mothers. ART was received by 24.3% of mothers, most initiating ART during pregnancy. At baseline (6 weeks of age) 264 (11.3%) children were infected with HIV. In children whose mothers received ART, the relative risk of diarrhea in children was 0.79 (95% CI 0.68-0.92), after we adjusted for multiple factors, including child HIV status and exclusive breastfeeding duration. Exclusive breastfeeding (relative risk 0.67, 95% CI 0.56-0.80) also was protective.

Conclusion: Our results provide additional support to increase ART coverage for all pregnant mothers, to control clinical HIV progression, reduce perinatal HIV infection, but also to reduce the risk of a major cause of death and morbidity in young children worldwide.

Trial registration: ClinicalTrials.gov: NCT00197730.

Keywords: ART; HIV; breastfeeding; pediatrics; sub-Saharan Africa.

Publication types

  • Observational Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Anti-HIV Agents / therapeutic use*
  • Breast Feeding
  • Child, Preschool
  • Diarrhea / etiology*
  • Diarrhea / prevention & control
  • Female
  • Follow-Up Studies
  • HIV Infections / complications
  • HIV Infections / drug therapy*
  • HIV Infections / prevention & control
  • HIV Infections / transmission
  • Humans
  • Infant
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical* / prevention & control
  • Male
  • Pregnancy
  • Pregnancy Complications, Infectious / drug therapy*
  • Prenatal Exposure Delayed Effects / etiology*
  • Prospective Studies
  • Protective Factors
  • Risk Factors
  • Tanzania
  • Treatment Outcome

Substances

  • Anti-HIV Agents

Associated data

  • ClinicalTrials.gov/NCT00197730